LoA Update: Repare Therapeutics’ Phase I RP-6306 transition score to next development stage in …,

The Phase I trial is recruiting 60 patients with genomic alterations that are sensitive … Preliminary data from this study is expected in 2022 and Repare has … of a drug progressing successfully from one development stage to the next., The Phase I trial is recruiting 60 patients with genomic alterations that are sensitive … Preliminary data from this study is expected in 2022 and Repare has … of a drug progressing successfully from one development stage to the next., Read More

Scroll to Top